颅内大型囊性动脉瘤血管内治疗后复发与再治疗的危险因素
该回顾性研究纳入2008至2017年在本机构接受血管内治疗的颅内囊性动脉瘤(≥8 mm)患者,分析复发与再治疗的危险因素。总复发率为25.7%(44/171),再治疗率为10.5%(18/171)。复发独立危险因素包括动脉瘤尺寸较大、破裂状态、初始不完全闭塞及低穹顶颈比。
要点
- 大型颅内囊性动脉瘤血管内治疗后总复发率为25.7%(44/171),再治疗率为10.5%(18/171)。
- 复发独立危险因素:动脉瘤尺寸较大(OR 1.32)、破裂状态(OR 3.91)、初始不完全闭塞(OR 2.72)、低穹顶颈比(OR 0.61)。
- 支架辅助弹簧圈(SAC)组复发率低于无支架组,高填塞密度组低于低填塞密度组。
核心结论
- 大型(≥8 mm)颅内囊性动脉瘤血管内治疗后复发的独立危险因素为动脉瘤尺寸较大、破裂状态、低穹顶颈比及初始不完全闭塞状态。
- SAC是降低相对大型(≥8 mm)脑动脉瘤血管内治疗后复发的有用方法。
研究设计与样本
- 回顾性研究,纳入2008至2017年在本机构接受血管内治疗的颅内囊性动脉瘤(≥8 mm)患者,共171例。
主要发现
- 总复发率为25.7%(44/171),总再治疗率为10.5%(18/171)。
- 复发独立危险因素:动脉瘤尺寸较大(OR 1.32;95%CI 1.17-1.51;p < 0.001)、破裂状态(OR 3.91;95%CI 1.44-10.90;p = 0.008)、初始不完全闭塞(OR 2.72;95%CI 1.18-6.41;p = 0.020)、低穹顶颈比(OR 0.61;95%CI 0.36-0.97;p = 0.047)。
- 无支架且低填塞密度(< 17.5%)组复发率为50%(14/28);SAC且低填塞密度组为37.5%(6/16);无支架且高填塞密度组为22.0%(20/91);SAC且高填塞密度组为11.1%(4/36)。
关键数值与推荐
- 复发独立危险因素:动脉瘤尺寸较大(OR 1.32;95%CI 1.17-1.51;p < 0.001)、破裂状态(OR 3.91;95%CI 1.44-10.90;p = 0.008)、初始不完全闭塞(OR 2.72;95%CI 1.18-6.41;p = 0.020)、低穹顶颈比(OR 0.61;95%CI 0.36-0.97;p = 0.047)。
- 无支架且低填塞密度(< 17.5%)组复发率为50%(14/28);SAC且低填塞密度组为37.5%(6/16);无支架且高填塞密度组为22.0%(20/91);SAC且高填塞密度组为11.1%(4/36)。
临床怎么用
- 作者认为SAC是降低相对大型(≥8 mm)脑动脉瘤血管内治疗后复发的有用方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Large intracranial aneurysm is challenging for both surgical and endovascular treatment. High recurrence and retreatment rates are still limitations for endovascular treatment. Analysing risk factors of recurrence after endovascular treatment can be useful for planning future treatment strategies. METHOD: We retrospectively reviewed patients with intracranial saccular aneurysm (≥ 8 mm) who underwent endovascular treatment from 2008 to 2017 at our institution. The demographic features, clinical information and angiographic results were analysed to reveal the risk factors for recurrence and retreatment. Subgroup analysis was performed according to packing density (PD) and stent insertion status. RESULTS: The total recurrence and retreatment rates were 25.7% (44/171) and 10.5% (18/171), respectively. Independent risk factors for recurrence after endovascular treatment were larger aneurysm size (OR 1.32; 95% CI 1.17-1.51; p < 0.001), ruptured status (OR 3.91; 95%CI 1.44-10.90; p = 0.008), initial incomplete occlusion (OR 2.72; 95%CI 1.18-6.41; p = 0.020), and low dome-to-neck ratio (OR 0.61; 95%CI 0.36-0.97; p = 0.047). The recurrence rate for the no-stent with low PD (< 17.5%) group was 50% (14/28); 37.5% (6/16) for stent-assisted coil (SAC) with low PD group, 22.0% (20/91) for no-stent with high PD group and 11.1% (4/36) for SAC with high PD group. CONCLUSION: The independent risk factors for recurrence after endovascular treatment in large (≥ 8 mm) intracranial saccular aneurysm were larger aneurysm size, ruptured status, low dome-to-neck ratio and initial incomplete occlusion state. SAC is a useful method for lowering recurrence after endovascular treatment for relatively large (≥ 8 mm) cerebral aneurysm.
引用
- Park YK, Bae HJ, Cho DY, et al. Risk factors for recurrence and retreatment after endovascular treatment of intracranial saccular aneurysm larger than 8 mm. Acta Neurochir (Wien). 2019. PMID: 30903289. doi:10.1007/s00701-019-03877-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。